Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.000.99%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.49M | -7.29M | -3.39M | -4.44M | -6.45M |
| Total Depreciation and Amortization | 39.00K | 29.00K | 19.00K | 21.00K | 22.00K |
| Total Amortization of Deferred Charges | 560.00K | 445.00K | 372.00K | 313.00K | 708.00K |
| Total Other Non-Cash Items | 974.00K | -383.00K | -3.12M | -553.00K | -763.00K |
| Change in Net Operating Assets | 5.91M | 5.32M | 3.98M | 2.51M | 4.20M |
| Cash from Operations | -11.00K | -1.88M | -2.14M | -2.15M | -2.29M |
| Capital Expenditure | -1.00K | -7.00K | -6.00K | -8.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | 4.00K | 4.00K | 4.00K | 4.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.17M | 2.17M | 2.17M | 2.51M | 2.51M |
| Cash from Investing | 2.17M | 2.17M | 2.17M | 2.50M | 2.50M |
| Total Debt Issued | 7.91M | 5.47M | 4.95M | 3.92M | 4.11M |
| Total Debt Repaid | -9.33M | -6.73M | -5.64M | -4.66M | -5.46M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.43M | -1.26M | -694.00K | -743.00K | -1.35M |
| Foreign Exchange rate Adjustments | 3.00K | 4.00K | 22.00K | 7.00K | -19.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 738.00K | -962.00K | -640.00K | -379.00K | -1.16M |